Recent News

View All

Friday, March 21, 2014
EntreMed Reports 2013 Fourth Quarter And Full Year Financial Results
Monday, January 13, 2014
EntreMed Files New Drug Global Clinical Trial Application For ENMD-2076 With China CFDA
Thursday, November 14, 2013
EntreMed Reports Third Quarter 2013 Financial Results
Thursday, October 31, 2013
EntreMed Commences Phase 2 Trial For ENMD-2076 In Ovarian Clear Cell Carcinomas
Tuesday, October 22, 2013
Data Presented For ENMD-2076 In Xenograft Models Of Human Hepatocellular Carcinoma

Stay Informed

Enter your e-mail address to receive press releases electronically. (Manage your subscription)